In addition, there is some evidence that acamprosate initiation following alcohol detoxification can mitigate relapse and PAWS (Gual & Lehert, 2001). Pregabalin has shown efficacy for treating uncomplicated AWS and related negative affective symptoms in a 2-week open-label study (Di Nicola et al., 2010) and a 2-week multicenter trial versus tiapride and lorazepam (Martinotti et al., 2010b). These findings were replicated in a 16-week multicenter trial against naltrexone, which found that pregabalin was well tolerated, improving withdrawal symptoms as well as naltrexone (Martinotti et al., 2010a). However, some of pregabalin’s pharmacokinetic improvements—such as quicker absorption and higher potency—have led to a concomitant increase in its abuse potential (Häkkinen et al., 2014; Schjerning et al., 2016). We screened 3,024 studies, from which 2,008 were unique citations and 1,016 were duplicate citations. From these, we excluded 1,416 records during the title and abstract screening phase, leaving 592 full-text articles for review.

Summary of evidence

Having people with first-hand how to make yourself pee knowledge to talk to will help put things into perspective and motivate you to keep going. Both acute and post-acute (PAWS) withdrawal symptoms exist because the body has to make adjustments for the sudden absence of the substance, whether it’s alcohol, opiates, marijuana or stimulants. PAWS refers to symptoms of substance withdrawal that last past, or develop after, the initial withdrawal period.

Prescription medication and other clinical treatment options

To our knowledge, this is the first systematic review to explore PAWS, which ASAM defines as a syndrome with persistent, subacute symptoms of irritability, anxiety, and sleep disturbance (ASAM, 2020). Although PAWS symptoms were first described more than baclofen habit forming six decades ago and are impairing, the importance of PAWS is its potential association with the risk for relapse. Some studies have examined the relationship between protracted alcohol withdrawal and specific gastrointestinal hormones, given the established association between chronic alcohol use and pancreatic function. One such hormone is plasma pancreatic polypeptide (PP), which inhibits pancreatic exocrine function, such as amylase secretion and other digestive enzymes (Fink et al., 1983; Hajnal et al., 1993). PP levels were significantly higher in individuals with AUD than in controls and remained elevated even 2 weeks following acute withdrawal completion (Fink et al., 1983). Therefore, alcohol-related gastrointestinal dysfunction appears to persist into PAWS and may help explain the abnormal pancreatic function seen frequently in AUD (Fink et al., 1983).

Support for Me and My Family

Most symptoms last for a few days at a time, although this is dependent on the type of alcohol or drug addiction, and the amount and frequency of substance use (every person’s withdrawal pattern is a little different). Typically, the brain recalibration process takes anywhere from six months to two years before the brain once again naturally produces endorphins and dopamine. Often, symptoms are triggered by stress or brought on by situations involving people, places or things that remind the individual of using. Many people in recovery describe the symptoms of PAWS as ebbing and flowing like a wave or having an «up and down» roller coaster effect. In the early phases of abstinence from substance use, symptoms can change by the minute. As individuals move into long-term recovery from alcohol or drug dependence, the symptoms occur less and less frequently.

1. Subsequently, 16 treatment studies met the inclusion criteria (Figure 1).
2. The Food and Drug Administration (FDA) confirms that benzodiazepine withdrawal symptoms can last weeks to years.
3. Flumazenil was found to be more effective than placebo in reducing feelings of hostility and aggression in patients who had been free of benzodiazepines for 4 to 266 weeks.31 This may suggest a role for flumazenil in treating protracted benzodiazepine withdrawal symptoms.
4. Treatment options for alcohol withdrawal syndrome typically involve supportive care to ease the effect of the symptoms.
5. If your plate is full, try to avoid adding unnecessary responsibilities to the mix.

Write them down, keep them with you, and always remind yourself that what you’re feeling is nothing more than your brain rewiring itself. It is worth keeping in mind that the symptoms of withdrawal can vary greatly, depending on the substance and the person’s response. We conducted a PRISMA (Preferred Reporting Items for Systematic Revision and Meta-Analyses)-guided scoping review of the published PAWS literature, searching six electronic databases (from their inception through December 2020) for English-language randomized and nonrandomized studies.

Building on Wellman’s findings, Segal and colleagues (1970) were the first to coin the term “protracted withdrawal syndrome” in 1960, describing neurovegetative and emotional instability alcohol gallbladder symptoms persisting long after acute withdrawal had subsided. Following Segal, Kissin (1979) described several protracted alcohol abstinence syndrome cases in 1979, emphasizing their importance to relapse prevention. Another important aspect of PAWS is the variation in the symptoms occurring in the post-acute withdrawal period, degree of impairment, severity, frequency, duration, and association with the specific substance of use. To that end, it may be less clinically helpful to consider these symptoms as a single construct, particularly in the case of AUD.

We also recognize that our work takes place on historical and contemporary Indigenous lands, including the territories of Treaties 6, 7 & 8 and the homeland of the Métis. We also acknowledge the many Indigenous communities that have been forged in urban centers across Alberta. Symptoms can become severe, and it can be difficult to predict which people will develop life-threatening symptoms. Chronic alcohol use can cause complex changes in their brain, including to the neurotransmitters dopamine and gamma-aminobutyric acid (GABA), which affect excitement and a person’s sense of reward. Acute withdrawal happens just after you stop using a substance or medication, while PAWS can happen for weeks, months, or even years after you cease use.

The continued use of alcohol causes changes in the central nervous system and neurotransmitter production in the brain. When the supply of alcohol is suddenly stopped or decreased, withdrawal symptoms can develop. The production of these neurotransmitters is affected when a person stops or significantly reduces alcohol intake. After the acute withdrawal stage, some uncomfortable symptoms may linger. Although PAWS can be challenging, there are ways to manage the symptoms and successfully avoid using the substance again.